Marc Began - 25 May 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role
VP & General Counsel
Signature
/s/ Ian Mcleod (by power of attorney)
Issuer symbol
ABMD
Transactions as of
25 May 2021
Transactions value $
$0
Form type
4
Date filed
27 May 2021, 16:44
Next filing
02 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABMD Common Stock, $0.01 par value Award $0 +2K +44.73% $0.00 6.47K 25 May 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABMD Stock Option (Right to Buy) Award $0 +2.96K $0.00 2.96K 25 May 2021 Common Stock 2.96K $283.88 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 7K 25 May 2021 Common Stock 7K $266.39 Direct F2, F3
holding ABMD Stock Option (Right to Buy) 5.13K 25 May 2021 Common Stock 5.13K $223.90 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25, 2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates.
F2 Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F3 These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.